About BIA Separations
BIA Separations is a company based in Villach (Austria) founded in 1998 was acquired by Sartorius in October 2020. BIA Separations has raised $1.69 million across 2 funding rounds from investors including Sartorius, European Union and Meta Group. The company has 2 employees as of December 31, 2022. BIA Separations offers products and services including CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System. BIA Separations operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
- Headquarter Villach, Austria
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bia Separations Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BIA Separations
BIA Separations offers a comprehensive portfolio of products and services, including CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System.
Columns for efficient purification of large biomolecules in bioprocessing.
Platforms for process development and analysis of biomolecules like pDNA and mRNA.
System for nucleic acid extraction and purification in biomanufacturing.
Funding Insights of BIA Separations
BIA Separations has successfully raised a total of $1.69M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $390.05 thousand completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BIA Separations
BIA Separations has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sartorius, European Union and Meta Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused Seed to Growth stage VC firm investing in Europe
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Laboratory and biopharmaceutical equipment is developed for production processes.
|
Locked | Locked | Locked |
Investor details for BIA Separations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BIA Separations
Investment portfolio details for BIA Separations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BIA Separations
Detailed financials for BIA Separations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bia Separations Comparisons
Peer comparison for BIA Separations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BIA Separations
BIA Separations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and Sepragen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provides liquid chromatography solutions
|
|
| Locked | Locked | Locked |
Biomolecular separation technologies are enabled for bioprocessing applications.
|
Detailed competitors of BIA Separations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bia Separations
Complete news archive for BIA Separations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BIA Separations
BIA Separations was founded in 1998 and raised its 1st funding round 17 years after it was founded.
BIA Separations is headquartered in Villach, Austria. It is registered at Villach, Karnten, Austria.
BIA Separations is a funded company, having raised a total of $1.69M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at BIA Separations is 2.
BIA Separations was established in 1998 in Villach, Austria, within the biotechnology sector. Proprietary short monolithic chromatographic columns are manufactured and distributed for laboratory and industrial use, relying on Convective Interaction Media (CIM) technology. These columns facilitate purification of large biomolecules, including viral vectors, vaccines, plasmid DNA, and proteins such as immunoglobulins G and M. Operations support research, pilot-scale, and production applications across biotechnology processes.
BIA Separations's top competitors include ChromaTan, Sepragen and Sepax Technologies.
BIA Separations offers CIMmultus®, PATfix Analytical Platforms, and In-line Lysis System.
BIA Separations has 3 investors. Key investors include Sartorius, European Union, and Meta Group.